Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 2, 1999, Pages 287-290

  Salminen, Ulla Stina ^a,b   Viljanen, Timo U T ^c   Valtonen, Ville V ^b   Ikonen, Timo E H ^a   Sahlman, Antero E ^a   Harjula, Ari L J ^a,b  

^a Deaconess Hospital in Helsinki   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Department of Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART SURGERY; HUMAN; INFECTION RATE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; RANDOMIZED CONTROLLED TRIAL; WOUND INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CEFTRIAXONE; CEPHALOSPORINS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 0032771440     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.2.287     Document Type: Article

References (10)

1. Slaughter, M. S., Olson, M. M., Lee, J. T. & Ward, H. B. (1993). A fifteen-year wound surveillance study after coronary artery bypass. Annals of Thoracic Surgery 56, 1063-8.
2. Sisto, T., Laurikka, J. & Tarkka, M. (1994). Ceftriaxone versus cefuroxime for infection prophylaxis in coronary bypass surgery. Scandinavian Journal of Thoracic and Cardiovascular Surgery 28, 143-8.
3. Hall, J. C., Christiansen, K., Carter, M. J., Edwards, M. G., Hodge, A. J., Newman, M. A. et al. (1993). Antibiotic prophylaxis in cardiac operations. Annals of Thoracic Surgery 56, 916-22.
4. Farber, B. F., Karchmer, A. W., Buckley, M. J. & Moellering, R. C. (1983). Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen. Journal of Thoracic and Cardiovascular Surgery 85, 933-5.
5. Ariano, R. E. & Zhanel, G. G. (1991). Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal. Drug Intelligence and Clinical Pharmacy 25, 478-84.
6. Bryan, C. S., Morgan, S. L., Jordan, A. B., Smith, C. W., Sutton, J. P. & Gangemi, J. D. (1984). Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery. Antimicrobial Agents and Chemotherapy 25, 37-9.
7. Almassi, G. H., Edmiston, C. E. & Olinger, G. N. (1989). Tissue and mediastinal fluid levels of a long-acting cephalosporin in cardiac surgical patients. Current Therapeutic Research 45, 447-52.
8. Barie, P. S. (1998) Antibiotic-resistant Gram-postive cocci: implications for surgical practice. World Journal of Surgery 22, 118-26.
9. Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasati, S., Hosada, Y., Hori, S. et al. (1998). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-3.
10. Leaper, D. J. (1998). Use of antibiotic prophylaxis in clean non-implant wounds. Journal of Antimicrobial Chemotherapy 41, 501-4.